Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 72 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 6200597

    Formulation and use of carotenoids in treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 13, 2001 · Expires Mar 8, 2021

    expired

  2. US 6197754

    Suppression of tumor growth by a mini-E1A gene

    The Board of Regents of the University of Texas System · Granted Mar 6, 2001 · Expires Mar 1, 2021

    expired

  3. US 6194176

    Recombinant expression of proteins from secretory cell lines

    The Board of Regents of the University of Texas System · Granted Feb 27, 2001 · Expires Feb 22, 2021

    expired

  4. US 6194481

    Mechanically strong and transparent or translucent composites made using zirconium oxide nanoparticles

    The Board of Regents of the University of Texas System · Granted Feb 27, 2001 · Expires Feb 22, 2021

    expired

  5. US 6184224

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Feb 6, 2001 · Expires Feb 1, 2021

    expired

  6. US 6184254

    Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors

    The Board of Regents of the University of Texas System · Granted Feb 6, 2001 · Expires Feb 1, 2021

    expired

  7. US 6172212

    Pea3 is a tumor suppressor

    The Board of Regents of the University of Texas System · Granted Jan 9, 2001 · Expires Jan 4, 2021

    expired

  8. US 6171856

    Methods and compositions relating to no-mediated cytotoxicity

    The Board of Regents of the University of Texas System · Granted Jan 9, 2001 · Expires Jan 4, 2021

    expired

  9. US 6165461

    Tao protein kinases and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  10. US 6165440

    Radiation and nanoparticles for enhancement of drug delivery in solid tumors

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  11. US 6166079

    DFMO for the treatment or prevention of cervical intraepithelial neoplasia

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  12. US 6165484

    EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  13. US 6165745

    Recombinant production of immunoglobulin-like domains in prokaryotic cells

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  14. US 6165990

    Antisense polynucleotide

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  15. US 6166193

    Polynucleotides encoding MY1 receptor

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  16. US 6156321

    Tissue factor methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Dec 5, 2000 · Expires Nov 30, 2020

    expired

  17. US 6143290

    Tumor regression by adenovirus expression of wild-type p53

    The Board of Regents of the University of Texas System · Granted Nov 7, 2000 · Expires Nov 2, 2020

    expired

  18. US 6140364

    Arachidonic acid metabolite, 16-HETE

    The Board of Regents of the University of Texas System · Granted Oct 31, 2000 · Expires Oct 26, 2020

    expired

  19. US 6132729

    Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired

  20. US 6132730

    Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired

  21. US 6133320

    Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

    The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired

  22. US 6110889

    Peptide tumor cell growth inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 29, 2000 · Expires Aug 24, 2020

    expired

  23. US 6110744

    Diminishing viral gene expression by promoter replacement

    The Board of Regents of the University of Texas System · Granted Aug 29, 2000 · Expires Aug 24, 2020

    expired

  24. US 6107457

    Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth

    The Board of Regents of the University of Texas System · Granted Aug 22, 2000 · Expires Aug 17, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.